Sanj K. Patel
CHAIRMAN & CEO at Kiniksa Pharmaceuticals International plc
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Kiniksa Pharmaceuticals International plc, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kiniksa Pharmaceuticals International plc June 3, 202597.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +9,991 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +9,991 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +6,481 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +6,481 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +6,237 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +6,237 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +8,609 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +8,609 | — | — |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Shares withheld for tax | −15,144 | $79.28 | $1,200,616 |
| Sep 1, 2026 | Kiniksa Pharmaceuticals International plc | Shares withheld for tax | −15,144 | $79.28 | $1,200,616 |
| Jun 1, 2026 | Kiniksa Pharmaceuticals International plc | Derivative conversion | +900,000 | — | — |
| May 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +48,565 | $30.93 | $1,502,115 |
| May 1, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −48,565 | $54.02 | $2,623,481 |
| Apr 30, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,141 | $30.93 | $66,221 |
| Apr 30, 2026 | Kiniksa Pharmaceuticals International plc | Open-market sale | −2,141 | $54.01 | $115,635 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.